1. Nebivolol

   • Paul A. J. Janssen

   Introduction 26 October 2012 Pages: 1 - 2

2. Comparative Study of the Binding Properties of Cloned Human β₁- and β₂-Adrenergic Receptors Expressed in Escherichia coli

   • W. H. M. L. Luyten
   • P. J. Pauwels
   • J. E. Leysen

   Section 1 26 October 2012 Pages: 3 - 12

3. Animal Pharmacology of Nebivolol

   • W. J. Janssens
   • R. Xhonneux
   • P. A. J. Janssen

   Section 1 26 October 2012 Pages: 13 - 24

4. Clinical Pharmacokinetics of Nebivolol

   • A. Van Peer
   • E. Snoeck
   • J. Heykants

   Section 1 26 October 2012 Pages: 25 - 30

5. Clinical Pharmacology of Nebivolol

   • J. S. McLay
   • N. Irvine
   • D. G. McDevitt

   Section 1 26 October 2012 Pages: 31 - 32

6. Cardiovascular, Respiratory and Metabolic Effects of Nebivolol During Maximal and Submaximal Exercise Performance

   • E. W. Derman
   • M. Haus
   • T. D. Noakes

   Section 2 26 October 2012 Pages: 33 - 39

7. Noninvasive Cardiac Haemodynamics of Nebivolol

   • J. De Crée
   • H. Geukens
   • H. Verhaegen

   Section 2 26 October 2012 Pages: 40 - 50

8. Effects of Nebivolol on Haemodynamics, Cardiac Dimensions and Function, Cardiovascular Reflexes and Biochemical Measures of Sympathetic Activity in Normal Human Subjects

   • Garry Jennings
   • M. Esler
   • G. Eisenhofer

   Section 2 26 October 2012 Pages: 51 - 59

9. Invasive Haemodynamics of Nebivolol in Hypertensive Patients

   • L. M. A. B. Van Bortel
   • P. M. H. Schiffers
   • J. M. V. Mooij

   Section 3 26 October 2012 Pages: 60 - 60

10. Nebivolol Improves the Vessel Wall Properties of the Common Carotid Artery

    • L. M. A. B. Van Bortel
    • T. Van Merode
    • H. A. J. Struyker Boudier

    Section 3 26 October 2012 Pages: 61 - 63

11. Haemodynamic Effects of Nebivolol in Patients with Coronary Artery Disease

    • Stephan Brune
    • Ulrich Tebbe
    • K.-U. Seiler

    Section 3 26 October 2012 Pages: 64 - 68

12. Pilot Study of Cardiovascular Effects of Nebivolol in Congestive Heart Failure

    • Ph. Lechat
    • S. Boutelant
    • Y. Grosgogeat

    Section 3 26 October 2012 Pages: 69 - 81

13. Effect of Nebivolol on Survival of Cardiomyopathic Hamsters with Congestive Heart Failure

    • Luc Ver Donck
    • L. Wouters
    • P. A. J. Janssen

    Section 3 26 October 2012 Pages: 82 - 85

14. Antianginal and Anti-Ischaemic Activity of Nebivolol in Stable Angina of Effort

    • Angelo Cherchi
    • C. Lai
    • E. Onnis

    Section 3 26 October 2012 Pages: 86 - 96

15. Results of a Pilot Study on the Tolerability of High-Dose Nebivolol in Essential Hypertension

    • W. Flamenbaum
    • P. Weber
    • S. Giuetino

    Section 4 26 October 2012 Pages: 97 - 97

16. Effects of Nebivolol on Blood Pressure, Hormones and Cardiac Function in Chinese Subjects with Essential Hypertension

    • Thomas Y. K. Chan
    • K. S. Woo
    • M. G. Nicholls

    Section 4 26 October 2012 Pages: 98 - 104

17. Nebivolol in Hypertensive Patients

    • L. M. A. B. Van Bortel
    • J. Joosten
    • J. Mooij

    Section 4 26 October 2012 Pages: 105 - 106

18. Nebivolol Versus Metoprolol in the Treatment of Hypertension

    • O. Uhlíř
    • M. Fejfuša
    • K. Zeman

    Section 4 26 October 2012 Pages: 107 - 110

19. Differential Effects of Nebivolol on Adrenoceptors in the Heart and in Resistance Arterioles in the Rat

    • W. Loots
    • F. De Clerck

    Section 5 26 October 2012 Pages: 111 - 114

20. Differential Effects of Nebivolol, Atenolol and Propranolol on Heart Rate and Bronchoconstrictor Responses to Histamine in the Guinea-Pig

    • F. De Clerck
    • L. Van Gorp
    • P. A. J. Janssen

    Section 5 26 October 2012 Pages: 115 - 117

21. Nebivolol Induces Endothelium-Dependent Relaxations of Canine Arteries

    • Yuansheng Gao
    • Tetsuhiko Nagao
    • Paul M. Vanhoutte

    Section 5 26 October 2012 Pages: 118 - 119

22. The Receptor Binding Profile of the New Antihypertensive Agent Nebivolol and its Stereoisomers Compared with Various β-Adrenergic Blockers

    • J. E. Leysen
    • P. J. Pauwels
    • P. A. J. Janssen

    Section 5 26 October 2012 Pages: 120 - 121

23. β-Adrenergic Receptor Coupled Adenylate Cyclase Activity in Living Cardiac Cells

    • P. J. Pauwels
    • J. E. Leysen

    Section 5 26 October 2012 Pages: 122 - 122

24. β-Adrenoceptor Blocking Properties of dl-Nebivolol and its Enantiomers in the Pithed Normotensive Rat

    • Jürgen Schneider
    • C. Fruh
    • T. Peters

    Section 5 26 October 2012 Pages: 123 - 128

25. Modulation of Isoprenaline-Induced Metabolic and Cardiovascular Responses in Dogs by Nebivolol, Atenolol and Propranolol

    • Charles R. Bowden
    • Carol S. Marchione

    Section 5 26 October 2012 Pages: 129 - 130

26. Antihypertensive Effects of Oral Nebivolol in the Conscious Dog with 2-Kidney, 1-Wrapped Perinephritic Hypertension

    • Linda Gambone
    • Siu Po Sit

    Section 5 26 October 2012 Pages: 131 - 133

27. Cytoprotective Effects of Nebivolol

    • G. Vandeplassche
    • L. Ver Donck
    • M. Borgers

    Section 5 26 October 2012 Pages: 134 - 136

28. The Interaction of Nebivolol with Vascular Presynaptic β-Adrenoceptors in the Freely Moving Rat

    • J. X. M. van Rossum
    • V. I. Tarizzo
    • J. Zaagsma

    Section 5 26 October 2012 Pages: 137 - 139

29. Comparison of Left Ventricular Haemodynamics of Nebivolol and Metoprolol in Patients with Acute Myocardial Infarction

    • J. De Crée
    • A. Van Rossum
    • H. Verhaegen

    Section 5 26 October 2012 Pages: 140 - 141

30. The Effect of Nebivolol in Patients with Left Ventricular Diastolic Dysfunction

    • J. De Crée
    • J. Vanwelden
    • H. Verhaegen

    Section 5 26 October 2012 Pages: 142 - 143

31. Influence of Nebivolol on Cardiovascular Haemodynamics During Postural Changes and Isometric Exercise

    • D. Duprez
    • R. Lefebvre
    • D. L. Clement

    Section 5 26 October 2012 Pages: 144 - 145

32. Cardiac Haemodynamics with Nebivolol and Metoprolol in Patients with Essential Hypertension

    • P. Havránek
    • Z. Stepanek

    Section 5 26 October 2012 Pages: 146 - 151

33. Nebivolol

    • P. J. Blankestijn
    • A. H. van den Meiracker
    • M. A. D. H. Schalekamp

    Section 5 26 October 2012 Pages: 152 - 154

34. Effects of Nebivolol on Left Ventricular Function in Patients with Essential Hypertension

    • Ramiro A. Sanchez
    • Tomas Cianciulli
    • Enrique J. Marco

    Section 5 26 October 2012 Pages: 155 - 160

35. Haemodynamic Effects of Nebivolol in Poor and Extensive Metabolisers

    • P. Van Rooy
    • J. De Crée

    Section 5 26 October 2012 Pages: 161 - 163

36. Comparison of the Effects of Nebivolol and Metoprolol on Left Ventricular Diastolic Function in Patients with Hypertension

    • J. Vojáček
    • K. Kolář

    Section 5 26 October 2012 Pages: 164 - 166

37. Evaluation of Cardiac Function with Radionuclide Angiography in Hypertension

    • J. A. Saavedra
    • A. I. Santos
    • Carlos Ribeiro

    Section 5 26 October 2012 Pages: 167 - 169

38. β-Blocking Capacity of Nebivolol Compared with Atenolol

    • S. Bygdeman
    • B. Lundgren
    • S. Rosfors

    Section 5 26 October 2012 Pages: 170 - 172

39. β-Adrenoceptor Blockade and β₁ -Selectivity of Nebivolol and Atenolol

    • L. M. A. B. Van Bortel
    • M. J. F. Kool
    • H. A. J. Struyker Boudier

    Section 5 26 October 2012 Pages: 173 - 173

40. Nebivolol

    • P. Van Rooy
    • L. Van Nueten
    • J. De Crée

    Section 5 26 October 2012 Pages: 174 - 175

41. Exercise Tolerance with Nebivolol and Atenolol

    • L. M. A. B. Van Bortel
    • M. A. van Baak

    Section 5 26 October 2012 Pages: 176 - 176

42. Dose-Dependent β-Sympatholytic Activity of Nebivolol in Comparison with Atenolol

    • D. Trenk
    • M. Buschmann
    • E. Jähnchen

    Section 5 26 October 2012 Pages: 177 - 179

43. Long Term Therapy with Nebivolol in Patients with Hypertension

    • Carlos Cobo
    • L. Alcocer

    Section 5 26 October 2012 Pages: 180 - 182

44. A Study to Assess the Effects of Nebivolol on Sedation and Psychomotor Performance in Normal Volunteers

    • C. Idzikowski
    • S. Gould
    • S. Downes

    Section 5 26 October 2012 Pages: 183 - 185

45. β-Blockade Prevents the Adverse Effects of Acute Stress

    • I. James
    • S. Jordan
    • S. E. Gould

    Section 5 26 October 2012 Pages: 186 - 187

46. Effects of Nebivolol on Dynamic Exercise in Patients with Hypertension

    • A. P. Machado
    • C. Moreira
    • J. A. Saavedra

    Section 5 26 October 2012 Pages: 188 - 189

47. Nebivolol in Hypertension

    • G. Sieben
    • L. Van Nueten
    • J. Symoens

    Section 5 26 October 2012 Pages: 190 - 192

48. Nebivolol in Hypertension

    • G. Sieben
    • L. Van Nueten
    • J. Symoens

    Section 5 26 October 2012 Pages: 193 - 195

49. Effects of Nebivolol, Atenolol and Propranolol on Airway β-Adrenergic Responsiveness in Normal Subjects

    • A. F. Mohammed
    • G. Hulks
    • S. E. Gould

    Section 5 26 October 2012 Pages: 196 - 198

50. A Single-Blind Dose-Ranging Study of the Effect of Nebivolol in Patients with Angina Pectoris

    • Göran Ulvenstam

    Section 5 26 October 2012 Pages: 199 - 200